Evidence map›Paper›PMID 31904590›Full record

ArticleThe Journal of clinical investigation2020

Disrupted ER membrane protein complex-mediated topogenesis drives congenital neural crest defects.

Jonathan Marquez, June Criscione, Rebekah M Charney, Maneeshi S Prasad, Woong Y Hwang, Emily K Mis, Martín I García-Castro, Mustafa K Khokha

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. METTL3-dependent mCell death & disease · 2024
    Article
  6. Article
  7. Article
  8. Technologies to Study Genetics and Molecular Pathways.Advances in experimental medicine and biology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Novel compound heterozygous variants inFrontiers in molecular neuroscience · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jonathan MarquezPediatric Genomics Discovery Program, Department of Pediatrics and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
June CriscionePediatric Genomics Discovery Program, Department of Pediatrics and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Rebekah M CharneyDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, California, USA.
Maneeshi S PrasadDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, California, USA.
Woong Y HwangPediatric Genomics Discovery Program, Department of Pediatrics and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Emily K MisPediatric Genomics Discovery Program, Department of Pediatrics and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Martín I García-CastroDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, California, USA.
Mustafa K KhokhaPediatric Genomics Discovery Program, Department of Pediatrics and Genetics, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · USUniversity of California, Riverside · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
Molecular Interactions During Neural Crest FormationR01DE017914 · NIDCR · YALE UNIVERSITY · PI GARCIA-CASTRO, MARTIN I. · 2007 to 2025
$6.3M
A system approach to the analysis of Heterotaxy Candiate GenesR01HD081379 · NICHD · YALE UNIVERSITY · PI KHOKHA, MUSTAFA K · 2014 to 2018
$2.7M
Identification of a novel regulatory program underlying the early specification of Neural Crest cellsF32DE027862 · NIDCR · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI CHARNEY, REBEKAH · 2018 to 2020
$133k
NCATS NIH HHS UL1 TR001863NICHD NIH HHS R01 HD081379NIDCR NIH HHS F32 DE027862NIDCR NIH HHS R01 DE017914NIGMS NIH HHS T32 GM007205NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

Multipass membrane proteins have a myriad of functions, including transduction of cell-cell signals, ion transport, and photoreception. Insertion of these proteins into the membrane depends on the endoplasmic reticulum (ER) membrane protein complex (EMC). Recently, birth defects have been observed in patients with variants in the gene encoding a member of this complex, EMC1. Patient phenotypes include congenital heart disease, craniofacial malformations, and neurodevelopmental disease. However, a molecular connection between EMC1 and these birth defects is lacking. Using Xenopus, we identified defects in neural crest cells (NCCs) upon emc1 depletion. We then used unbiased proteomics and discovered a critical role for emc1 in WNT signaling. Consistent with this, readouts of WNT signaling and Frizzled (Fzd) levels were reduced in emc1-depleted embryos, while NCC defects could be rescued with β-catenin. Interestingly, other transmembrane proteins were mislocalized upon emc1 depletion, providing insight into additional patient phenotypes. To translate our findings back to humans, we found that EMC1 was necessary for human NCC development in vitro. Finally, we tested patient variants in our Xenopus model and found the majority to be loss-of-function alleles. Our findings define molecular mechanisms whereby EMC1 dysfunction causes disease phenotypes through dysfunctional multipass membrane protein topogenesis.

Indexed as

Wnt Signaling PathwayAnimalsDisease Models, AnimalEndoplasmic ReticulumIntracellular MembranesMultiprotein ComplexesNeural CrestNeurodevelopmental DisordersXenopusXenopus ProteinsMultiprotein ComplexesXenopus ProteinsCardiovascular diseaseDevelopmentEmbryonic developmentGeneticsMonogenic diseases

Identifiers

PMID31904590
PMCPMC6994125
OpenAlexW2996912889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.